author-photo

Yuki Akazawa

43

Papers

218

Citations

Citation Trend

Filter By

Papers (30) Sort By

Journal Conference Others

EGFR-mutant lung adenocarcinoma associated with antisynthetase syndrome successfully treated with osimertinib.

2021 Thoracic Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Expectoration of tonsillar metastasis of pulmonary pleomorphic carcinoma after pseudoprogression: A case report.

2021 Thoracic Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B)

2021 International Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Mechanical Thrombectomy for Acute Middle Cerebral Artery Occlusion Caused by Tumor Embolism: A Case Report

2020 Journal of Neuroendovascular Therapy
Show All
- Source
- Cite
- Save
Citations (0)
Safety and effectiveness of pirfenidone combined with carboplatin-based chemotherapy in patients with idiopathic pulmonary fibrosis and non-small cell lung cancer: A retrospective cohort study.

2020 Thoracic Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Propensity score–weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non–small cell lung cancer (WJOG10217L)

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (15)
EP1.01-13 A Phase 2 Trial Assessing Osimertinib Activity Against Leptomeningeal Carcinomatosis in EGFR-Mutant Lung Cancer

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
MA03.11 Chemotherapy After PD-1 Inhibitors Versus Chemotherapy Alone in Patients with Non–Small Cell Lung Cancer (WJOG10217L)

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
520PA phase II study to evaluate abscopal effect by palliative radiation therapy in nivolumab treatment for pretreated non-small cell lung cancer (HANSHIN 0116)

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune‐related adverse effect: A case report

2019 Thoracic Cancer
Show All
- Source
- Cite
- Save
Citations (4)